Mutational profiling in patients with MDS: Ready for every-day use in the clinic?

Best Practice and Research: Clinical Haematology

Volumn 28, Issue 1, 2015, Pages 32-42

  Bacher, Ulrike ^a   Kohlmann, Alexander ^a   Haferlach, Torsten ^a  

^a MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

amplicon deep sequencing; diagnostic algorithm; Keywords myelodysplastic syndrome (MDS); mutations; next generation sequencing; NGS

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; AMPLICON; ARTICLE; CELL STRUCTURE; CHROMOSOME ANALYSIS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENETIC ASSOCIATION; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; LIMIT OF DETECTION; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; MOLECULAR MUTATION ANALYSIS; MUTATION; MUTATION RATE; MYELODYSPLASTIC SYNDROME; NEXT GENERATION SEQUENCING; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SOMATIC MUTATION;

EID: 84964308918     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2014.11.005     Document Type: Review

References (42)

1. P. Greenberg, C. Cox, and M.M. Le Beau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 6 1997 2079 2088
2. P.L. Greenberg, H. Tuechler, and J. Schanz Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes Blood 120 12 2012 2454 2465
3. R. Brunning, A. Orazi, and U. Germing Myelodysplastic syndromes S. Swerdlow, E. Campo, N. Lee Harris, WHO classification of tumours of haematopoietic and lymphoid tissues 2008 87 93
4. E. Papaemmanuil, M. Cazzola, and J. Boultwood Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts N Engl J Med 365 15 2011 1384 1395
5. K. Yoshida, M. Sanada, and Y. Shiraishi Frequent pathway mutations of splicing machinery in myelodysplasia Nature 478 7367 2011 64 69
6. E. Papaemmanuil, M. Gerstung, and L. Malcovati Clinical and biological implications of driver mutations in myelodysplastic syndromes Blood 122 22 2013 3616 3627
7. T. Haferlach, Y. Nagata, and V. Grossmann Landscape of genetic lesions in 944 patients with myelodysplastic syndromes Leukemia 8 2014 241 247
8. L. Malcovati, E. Hellstrom-Lindberg, and D. Bowen Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet Blood 122 17 2013 2943 2964
9. S. Schnittger, U. Bacher, and C. Haferlach Diversity of the juxtamembrane and TKD1 mutations (Exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data Genes Chromosom Cancer 51 10 2012 910 924
10. S. Schnittger, W. Kern, and C. Tschulik Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML Blood 114 11 2009 2220 2231
11. F. Sanger, and A.R. Coulson A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase J Mol Biol 94 3 1975 441 448
12. D. Rossi, H. Khiabanian, and V. Spina Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia Blood 123 2014 2139 2147
13. M.L. Metzker Sequencing technologies - the next generation Nat Rev Genet 11 1 2010 31 46
14. A. Kohlmann, H.U. Klein, and S. Weissmann The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories Leukemia 25 12 2011 1840 1848
15. A. Kohlmann, V. Grossmann, and N. Nadarajah Next-generation sequencing - feasibility and practicality in haematology Br J Haematol 160 6 2013 736 753
16. A. Kohlmann, N. Nadarajah, and T. Alpermann Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease Leukemia 28 1 2014 129 137
17. M. Margulies, M. Egholm, and W.E. Altman Genome sequencing in microfabricated high-density picolitre reactors Nature 437 7057 2005 376 380
18. D.R. Bentley, S. Balasubramanian, and H.P. Swerdlow Accurate whole human genome sequencing using reversible terminator chemistry Nature 456 7218 2008 53 59
19. J.M. Rothberg, W. Hinz, and T.M. Rearick An integrated semiconductor device enabling non-optical genome sequencing Nature 475 7356 2011 348 352
20. V. Grossmann, A. Roller, and H.U. Klein Robustness of amplicon deep sequencing underlines its utility in clinical applications J Mol Diagn 15 4 2013 473 484
21. R.C. Green, J.S. Berg, and W.W. Grody ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Genet Med 15 7 2013 565 574
22. H.U. Klein, C. Bartenhagen, and A. Kohlmann R453Plus1Toolbox: an R/bioconductor package for analyzing Roche 454 sequencing data Bioinformatics 27 8 2011 1162 1163
23. S. Datta, S. Datta, and S. Kim Statistical analyses of next generation sequence data: a partial overview J Proteomics Bioinform 3 6 2010 183 190
24. R. Nielsen, J.S. Paul, and A. Albrechtsen Genotype and SNP calling from next-generation sequencing data Nat Rev Genet 12 6 2011 443 451
25. C. Ledergerber, and C. Dessimoz Base-calling for next-generation sequencing platforms Brief Bioinform 12 5 2011 489 497
26. H.L. Rehm, S.J. Bale, and P. Bayrak-Toydemir ACMG clinical laboratory standards for next-generation sequencing Genet Med 15 9 2013 733 747
27. M.J. Walter, D. Shen, and J. Shao Clonal diversity of recurrently mutated genes in myelodysplastic syndromes Leukemia 27 6 2013 1275 1282
28. F. Thol, B. Kolking, and F. Damm Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations Genes Chromosom Cancer 51 7 2012 689 695
29. K.V. Voelkerding, S. Dames, and J.D. Durtschi Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology J Mol Diagn 12 5 2010 539 551
30. J. Zernant, C. Schubert, and K.M. Im Analysis of the ABCA4 gene by next-generation sequencing Invest Ophthalmol Vis Sci 52 11 2011 8479 8487
31. E. Taskesen, M. Havermans, and K. van Lom Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling Blood 123 2014 3327 3335
32. J.P. Patel, M. Gonen, and M.E. Figueroa Prognostic relevance of integrated genetic profiling in acute myeloid leukemia N Engl J Med 366 12 2012 1079 1089
33. R. Bejar, K. Stevenson, and O. Abdel-Wahab Clinical effect of point mutations in myelodysplastic syndromes N Engl J Med 364 26 2011 2496 2506
34. V. Visconte, H.J. Rogers, and J. Singh SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes Blood 120 16 2012 3173 3186
35. M.J. Walter, L. Ding, and D. Shen Recurrent DNMT3A mutations in patients with myelodysplastic syndromes Leukemia 25 7 2011 1153 1158
36. F. Thol, I. Friesen, and F. Damm Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes J Clin Oncol 29 18 2011 2499 2506
37. G. Nikoloski, S.M. Langemeijer, and R.P. Kuiper Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes Nat Genet 42 8 2010 665 667
38. M. Jadersten, L. Saft, and A. Smith TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression J Clin Oncol 29 15 2011 1971 1979
39. M. Fernandez-Mercado, A. Burns, and A. Pellagatti Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes Haematologica 98 12 2013 1856 1864
40. V. Adema, and R. Bejar What lies beyond del(5q) in myelodysplastic syndrome? Haematologica 98 12 2013 1819 1821
41. A. Kon, L.Y. Shih, and M. Minamino Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms Nat Genet 45 10 2013 1232 1237
42. A. Kohlmann, U. Bacher, and S. Schnittger Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing Leuk Lymphoma 55 2014 1725 1734